| Pfizer-BioNTech COVID-19 vaccine
2BNT162b2; Tozinameran; Comirnaty |
Tozinameran - COVD-19 mRNA Vaccine COMIRNATY® |
BioNTech Manufacturing GmbH, Germany |
BioNTech Manufacturing GmbH, Germany |
31 December 2020 (1) |
| EU Nodes-AstraZeneca/ Oxford COVID-19 vaccine; Vaxzevria in Europe (formerly AZD1222 and ChAdOx1)* |
COVID-19 Vaccine (ChAdOx1-S ([recombinant]) |
AstraZeneca/SK Bioscience Co. Ltd, Republic of Korea |
AstraZeneca/SK Bioscience Co. Ltd, Republic of Korea |
15 February 2021 (2) |
| Serum Institute of India COVID-19 vaccine;
Covishield in India* |
COVID-19 Vaccine (ChAdOx1-S ([recombinant]) COVISHIELD™ |
Serum Institute of India Pvt. Ltd, India |
Serum Institute of India Pvt. Ltd, India |
15 February 2021 (3) |
| Janssen COVID-19 vaccine JNJ-78436735; Ad26.COV2-S (recombinant). |
COVID-19 Vaccine (Ad26.COV2-S [recombinant]) |
Janssen–Cilag International NV, Belgium |
Janssen–Cilag International NV, Belgium |
12 March 2021 (4) |
| AstraZeneca/SK BIO COVID-19 vaccine* |
COVID-19 Vaccine (ChAdOx1-S ([recombinant]) |
AstraZeneca AB, Sweden |
Catalent Anagni; CP Pharmaceuticals; |
15 April 2021 (5) |
| ModernaCOVID-19 vaccine mRNA-1273 |
COVID-19 mRNA Vaccine (nucleoside modified) |
Moderna Biotech |
Rovi Pharma Industrial Services, Spain |
30 April 2021 (6) |
| Sinopharm/ BIBP COVID-19 vaccine Inactivated SARS-CoV-2-vaccine (Vero cell); BBIBP-CorV |
COVID-19 Vaccine BIBP |
Beijing Institute of Biological Products Co., Ltd. (BIBP) |
Beijing, China |
07 May 2021 (7) |
| Sinovac COVID-19 vaccine CoronaVac; adsorbed COVID-19 vaccine |
COVD-19 mRNA Vaccine (vero cell) inactivated, CoronaVac |
Sinovac Life Sciences Co., Ltd. China |
Tianfu Street, Daxing Biomedicine Industrial Base of Zhongguancun Science Park, Daxing District, Beijing, P.R. China |
01 june 2021 (8) |